Statin Controversies: Response to the Letter from Tomlinson et al

Cardiovasc Drugs Ther. 2020 Jun;34(3):437-438. doi: 10.1007/s10557-020-06964-4.

Authors

Veronica Azemawah^{1

2}, Mohammad Reza Movahed^{1

2}, Patrick Centuori^{1

2}, Ryan Penaflor^{1

2}, Pascal L Riel^{1

2}, Steven Situ^{1

2}, Mehrdad Shadmehr¹, Mehrnoosh Hashemzadeh^{3

4}

Affiliations

¹ University of Arizona, Tucson, AZ, USA.
² Pima College, Tucson, AZ, USA.
³ University of Arizona, Tucson, AZ, USA. mhashemz1@yahoo.com.
⁴ Pima College, Tucson, AZ, USA. mhashemz1@yahoo.com.

PMID: 32172428
DOI: 10.1007/s10557-020-06964-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Hydroxymethylglutaryl-CoA Reductase Inhibitors*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors